Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, Cavalla P, Torri Clerici V, Ragonese P, Nociti V, Radaelli M, Laroni A, Buttari F, Lorefice L, Ferraro D, Gajofatto A, Prosperini L, Fantozzi R, Boffa L, Lanzillo R, Moccia M, Clerico M, De Luca G, Tomassini V, Calabrese M, Borrelli A, Paolicelli D, Maniscalco GT, Gazzola P, Gallo A, Solaro C, Cocco E, Gasperini C, Tortorella C; RIREMS (Rising Researchers in MS) group. Di Filippo M, et al. Among authors: lanzillo r. J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug 18. J Neurol Neurosurg Psychiatry. 2022. PMID: 34408003 No abstract available.
The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
Lolli F, Mazzanti B, Pazzagli M, Peroni E, Alcaro MC, Sabatino G, Lanzillo R, Brescia Morra V, Santoro L, Gasperini C, Galgani S, D'Elios MM, Zipoli V, Sotgiu S, Pugliatti M, Rovero P, Chelli M, Papini AM. Lolli F, et al. Among authors: lanzillo r. J Neuroimmunol. 2005 Oct;167(1-2):131-7. doi: 10.1016/j.jneuroim.2005.05.016. J Neuroimmunol. 2005. PMID: 16051375 Free article.
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.
Lavorgna L, Bonavita S, Ippolito D, Lanzillo R, Salemi G, Patti F, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, d'Ambrosio A, Bresciamorra V, Savettieri G, Zappia M, Alfano B, Gallo A, Simone I, Tedeschi G. Lavorgna L, et al. Among authors: lanzillo r. Mult Scler. 2014 Feb;20(2):220-6. doi: 10.1177/1352458513494958. Epub 2013 Jul 9. Mult Scler. 2014. PMID: 23838177
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M. Ristori G, et al. Among authors: lanzillo r. Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4. Neurology. 2014. PMID: 24306002 Free PMC article. Clinical Trial.
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).
Clerico M, Schiavetti I, De Mercanti SF, Piazza F, Gned D, Brescia Morra V, Lanzillo R, Ghezzi A, Bianchi A, Salemi G, Realmuto S, Sola P, Vitetta F, Cavalla P, Paolicelli D, Trojano M, Sormani MP, Durelli L. Clerico M, et al. Among authors: lanzillo r. JAMA Neurol. 2014 Aug;71(8):954-60. doi: 10.1001/jamaneurol.2014.1200. JAMA Neurol. 2014. PMID: 24977406 Clinical Trial.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Moccia M, Lanzillo R, Costabile T, Russo C, Carotenuto A, Sasso G, Postiglione E, De Luca Picione C, Vastola M, Maniscalco GT, Palladino R, Brescia Morra V. Moccia M, et al. Among authors: lanzillo r. J Neurol. 2015;262(4):961-7. doi: 10.1007/s00415-015-7666-y. Epub 2015 Feb 12. J Neurol. 2015. PMID: 25673130
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D, Lanzillo R, Vacchiano V, Realmuto S, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D'Ambrosio A, Montella P, Brescia Morra V, Savettieri G, Alfano B, Gallo A, Simone I, Viterbo R, Zappia M, Bonavita S, Tedeschi G. Patti F, et al. Among authors: lanzillo r. PLoS One. 2015 Mar 27;10(3):e0120754. doi: 10.1371/journal.pone.0120754. eCollection 2015. PLoS One. 2015. PMID: 25816303 Free PMC article.
The Framingham cardiovascular risk score in multiple sclerosis.
Moccia M, Lanzillo R, Palladino R, Maniscalco GT, De Rosa A, Russo C, Massarelli M, Carotenuto A, Postiglione E, Caporale O, Triassi M, Brescia Morra V. Moccia M, et al. Among authors: lanzillo r. Eur J Neurol. 2015 Aug;22(8):1176-83. doi: 10.1111/ene.12720. Epub 2015 Apr 27. Eur J Neurol. 2015. PMID: 25912468
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
Moccia M, Lanzillo R, Palladino R, Chang KC, Costabile T, Russo C, De Rosa A, Carotenuto A, Saccà F, Maniscalco GT, Brescia Morra V. Moccia M, et al. Among authors: lanzillo r. Mult Scler. 2016 Apr;22(5):659-67. doi: 10.1177/1352458515599075. Epub 2015 Sep 11. Mult Scler. 2016. PMID: 26362896
247 results